CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of kidney disease that caus...
Phase 2
Rochester, Minnesota, United States and 65 other locations
and pharmacokinetics of AZD1613 following subcutaneous or intravenous administration in participants with autosomal dominant polycystic kidney...
Phase 1
Rochester, Minnesota, United States and 14 other locations
safety, tolerability, pharmacokinetics (PK) and Pharmacodynamics (PD) of DISC-0974 in adult participants with Non-Dialysis Dependent Chronic Kidney...
Phase 1
Rochester, Minnesota, United States and 12 other locations
To evaluate the safety of tolvaptan in pediatric subjects with ARPKD
Phase 3
Rochester, Minnesota, United States and 22 other locations
This study is an open-label, multi-center study evaluating the clinical utility of Renasight in the diagnosis and management of kidney disease...
Rochester, Minnesota, United States and 30 other locations
The purpose of the study is to evaluate the effect of VX-407 on height-adjusted total kidney volume (htTKV), safety, tolerability, and pharm...
Phase 2
Rochester, Minnesota, United States and 20 other locations
A first-in-human study of KK8123 in adults with X-linked hypophosphatemia.
Phase 1, Phase 2
Rochester, Minnesota, United States and 8 other locations
The proposed study is designed to provide patients previously enrolled in Phase 1 and 2 studies of DCR-PHXC and their siblings (\<18 years old) long-...
Phase 3
Rochester, Minnesota, United States and 22 other locations
PLD (ADPLD) or associated with autosomal dominant polycystic kidney disease (ADPKD).In the Treatment Period of the trial, participa...
Phase 2, Phase 3
Rochester, Minnesota, United States and 10 other locations
or more. People can take part if they have cardiovascular or chronic kidney disease. People who have at least 2 health problems rel...
Phase 3
Rochester, Minnesota, United States and 553 other locations
Clinical trials
Research sites
Resources
Legal